相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of platelet function in essential thrombocythemia under different analytical conditions
Federico Lussana et al.
PLATELETS (2020)
Surface markers: An identity card of endothelial cells
Domenico Ribatti et al.
MICROCIRCULATION (2020)
Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease
Siddhartha Jaiswal et al.
NATURE REVIEWS CARDIOLOGY (2020)
Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis
Alexander G. Bick et al.
CIRCULATION (2020)
Elevated White Blood Cell Levels and Thrombotic Events in Patients With Polycythemia Vera: A Real-World Analysis of Veterans Health Administration Data
Shreekant Parasuraman et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis
Lukas Ronner et al.
BLOOD (2020)
Dual role of Jam3b in early hematopoietic and vascular development
Isao Kobayashi et al.
DEVELOPMENT (2020)
Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study
Anders Lindholm Sorensen et al.
HAEMATOLOGICA (2020)
Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm
Johanne Poisson et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Platelet Toll-Like Receptors Mediate Thromboinflammatory Responses in Patients With Essential Thrombocythemia
Cecilia P. Marin Oyarzun et al.
FRONTIERS IN IMMUNOLOGY (2020)
Thrombotic Risk Detection in Patients with Polycythemia Vera: The Predictive Role of DNMT3A/TET2/ASXL1 Mutations
Adrian Segura-Diaz et al.
CANCERS (2020)
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses
Pierre-Edouard Debureaux et al.
BLOOD ADVANCES (2020)
Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia
Radhika Gangaraju et al.
BLOOD ADVANCES (2020)
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia
Monica Sacco et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
N-acetylcysteine inhibits thrombosis in a murine model of myeloproliferative neoplasm
Brianna M. Craver et al.
BLOOD ADVANCES (2020)
Vascular endothelial cell expression of JAK2(V617F) is sufficient to promote a pro-thrombotic state due to increased P-selectin expression
Alexandre Guy et al.
HAEMATOLOGICA (2019)
Neutrophils: back in the thrombosis spotlight
Denis F. Noubouossie et al.
BLOOD (2019)
Anticytokine Agents Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
Paul M. Ridker
CIRCULATION RESEARCH (2019)
Disruption of asxl1 results in myeloproliferative neoplasms in zebrafish
Evisa Gjini et al.
DISEASE MODELS & MECHANISMS (2019)
Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population
Sabrina Cordua et al.
BLOOD (2019)
TNF-α driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging
Pavel Davizon-Castillo et al.
BLOOD (2019)
Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis
Marta Zara et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study
Marie Warny et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Platelet-Neutrophil Crosstalk in Atherothrombosis
Joachim Pircher et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Vascular Endothelial Cell Biology: An Update
Anne Krueger-Genge et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation
Florian Perner et al.
CELLS (2019)
Experimental Modeling of Myeloproliferative Neoplasms
Lucie Lanikova et al.
GENES (2019)
Modeling myeloid malignancies with patient-derived iPSCs
Eirini P. Papapetrou
EXPERIMENTAL HEMATOLOGY (2019)
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Chronic inflammation in the etiology of disease across the life span
David Furman et al.
NATURE MEDICINE (2019)
Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis
Alessandra Carobbio et al.
BLOOD ADVANCES (2019)
Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms A Population-Based Cohort Study
Malin Hultcrantz et al.
ANNALS OF INTERNAL MEDICINE (2018)
Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1 and Cathepsin G
Eduardo J. Folco et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia
Veronika Buxhofer-Ausch et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
Impact of hydroxycarbamide and interferon-α on red cell adhesion and membrane protein expression in polycythemia vera
Megane Brusson et al.
HAEMATOLOGICA (2018)
Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms
Somedeb Ball et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2018)
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Paul M. Ridker et al.
LANCET (2018)
Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms
Ofir Wolach et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Impact of hydroxycarbamide and interferon-α on red cell adhesion and membrane protein expression in polycythemia vera
Megane Brusson et al.
HAEMATOLOGICA (2018)
Platelet-RBC interaction mediated by FasL/FasR induces procoagulant activity important for thrombosis
Christoph Klatt et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic Features
Anna Guadall et al.
THROMBOSIS AND HAEMOSTASIS (2018)
A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleeding
Constance C. F. M. J. Baaten et al.
BLOOD (2018)
Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2(V617F) Mice
Wei Wang et al.
CIRCULATION RESEARCH (2018)
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
J. Grinfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Neutrophil extracellular traps in immunity and disease
Venizelos Papayannopoulos
NATURE REVIEWS IMMUNOLOGY (2018)
Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera
A. Rottenstreich et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2017)
Blood endothelial cells: utility from ambiguity
Robert P. Hebbel
JOURNAL OF CLINICAL INVESTIGATION (2017)
Determining the role of inflammation in the selection of JAK2 mutant cells in myeloproliferative neoplasms
Jie Zhang et al.
JOURNAL OF THEORETICAL BIOLOGY (2017)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker et al.
LANCET (2017)
Genetic Risk Assessment in Myeloproliferative Neoplasms
Ayalew Tefferi et al.
MAYO CLINIC PROCEEDINGS (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Minimal residual disease or cure in MPNs? Rationales and perspectives on combination therapy with interferon-alpha2 and ruxolitinib
Mads Emil Bjorn et al.
EXPERT REVIEW OF HEMATOLOGY (2017)
Clinical significance of circulating microparticles in Ph-myeloproliferative neoplasms
Wenjuan Zhang et al.
ONCOLOGY LETTERS (2017)
Animal models of venous thrombosis
Hassan Albadawi et al.
CARDIOVASCULAR DIAGNOSIS AND THERAPY (2017)
The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review
K. C. Devendra et al.
ANNALS OF HEMATOLOGY (2017)
Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease
Mark P. Chao et al.
CELL STEM CELL (2017)
Animal Models of Thrombosis From Zebrafish to Nonhuman Primates Use in the Elucidation of New Pathologic Pathways and the Development of Antithrombotic Drugs
Pudur Jagadeeswaran et al.
CIRCULATION RESEARCH (2016)
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
S. Koschmieder et al.
LEUKEMIA (2016)
Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent
Petra Jilma-Stohlawetz et al.
THROMBOSIS RESEARCH (2016)
Neutrophil extracellular trap formation and circulating nucleosomes in patients with chronic myeloproliferative neoplasms
Cecilia P. Marin Oyarzun et al.
SCIENTIFIC REPORTS (2016)
Effect of Mutation Order on Myeloproliferative Neoplasms
Christina A. Ortmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia
Giada Rotunno et al.
BLOOD (2014)
Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm
Lamia Lamrani et al.
BLOOD (2014)
Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F
Pontus Lundberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed by in vivo two-photon imaging
T. P. Santisakultarm et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
JAK2V617F activates Lu/BCAM-mediated red cell adhesion in polycythemia vera through an EpoR-independent Rap1/Akt pathway
Maria De Grandis et al.
BLOOD (2013)
CANCER-ASSOCIATED THROMBOTIC DISEASE Myeloproliferative neoplasms and thrombosis
Tiziano Barbui et al.
BLOOD (2013)
Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
Roberto Marchioli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Late Outgrowth Endothelial Cells Resemble Mature Endothelial Cells and are Not Derived from Bone Marrow
Olga Tura et al.
STEM CELLS (2013)
Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort
Peter J. Campbell et al.
BLOOD (2012)
Prevalence of clinical venous thromboembolism in the USA: Current trends and future projections
S. B. Deitelzweig et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Resident Endothelial Cells Surrounding Damaged Arterial Endothelium Reendothelialize the Lesion
Yoshiaki Itoh et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Platelet-Leukocyte Interactions in Cardiovascular Disease and Beyond
Licia Totani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Limitations of collateral flow after occlusion of a single cortical penetrating arteriole
Nozomi Nishimura et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: Relationship with thrombosis occurrence and JAK2 V617F allele burden
Eduardo Arellano-Rodrigo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders
Zhaohui Ye et al.
BLOOD (2009)
Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia
Marijke C. Trappenburg et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia
Alessandra Carobbio et al.
BLOOD (2008)
Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera
Marina Marchetti et al.
BLOOD (2008)
Increased adhesion to endothelial cells of erythrocytes from patients with polycythemia vera is mediated by laminin α5 chain and Lu/BCAM
Marie-Paule Wautier et al.
BLOOD (2007)
V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules
Anna Falanga et al.
EXPERIMENTAL HEMATOLOGY (2007)
V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules (vol 35, jpg 702, 2007)
A. Falanga et al.
EXPERIMENTAL HEMATOLOGY (2007)
Vascular and neoplastic risk in a large cohort of patients with polycythemia vera
R Marchioli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
分享论文
